Nomura Securities Downgrades Imperva (IMPV) to Neutral; Acquisition Already Baked In

September 26, 2016 6:54 AM EDT
Get Alerts IMPV Hot Sheet
Price: $36.50 --0%

Rating Summary:
    17 Buy, 12 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 34 | New: 6
Trade IMPV Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Nomura Securities downgraded Imperva (NYSE: IMPV) from Buy to Neutral with a price target of $50.00, saying an acquisition is priced in.

Analyst Frederick Grieb commented, "After the market close on Thursday, September 22, Bloomberg published an article reporting that Imperva was seen as an acquisition target for Cisco and IBM. On Friday, Imperva’s stock traded up 21% to $52.56 on this news. We are downgrading Imperva to Neutral, from Buy after this move. While we believe that Imperva is a logical target for Cisco and IBM and the company’s management team are willing sellers, we also believe that Imperva’s stock price is now largely baking in a sale of the business, removing potential upside."

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $52.56 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Downgrades, Rumors

Related Entities

Nomura, Definitive Agreement

Add Your Comment